Metraipolis › archive › dc_f4eab4c323c0
Feasibility of the inhibitor development for cancer: A systematic approach for drug design — Europe PMC PMID:39173044
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/39173044
- DOI
- 10.1371/journal.pone.0306632
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T04:37:00.944Z
- SHA-256 of the archived text
a6a6dc5f9abdc59993e0f9162d36edf2f54b82543649bd77585ab6cb508aee2f- Stable URL of this page
https://metraipolis.com/documento/dc_f4eab4c323c0
How to cite
Feasibility of the inhibitor development for cancer: A systematic approach for drug design — Europe PMC PMID:39173044 — Europe PMC (en), https://europepmc.org/article/MED/39173044 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f4eab4c323c0 (Metraipolis archive dc_f4eab4c323c0, sha256 a6a6dc5f9abdc59993e0f9162d36edf2f54b82543649bd77585ab6cb508aee2f)
BibTeX
@misc{dcf4eab4c323c0,
title = {Feasibility of the inhibitor development for cancer: A systematic approach for drug design — Europe PMC PMID:39173044},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/39173044},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f4eab4c323c0; sha256 a6a6dc5f9abdc59993e0f9162d36edf2f54b82543649bd77585ab6cb508aee2f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39173044. Agents can read the archived copy with the MCP tool read_document.